LOGC LogicBio Therapeutics Inc
735
$2.07
$0.01
(0.48%)
| Watchers | 735 |
| 52-Wk Low | $0.2573 |
| 52-Wk High | $3.53 |
| Market Cap | $68.23M |
| Volume (M) | 153,044.00 |
| 52-Wk High | $3.53 |
| 52-Wk Low | $0.2573 |
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: VisiongainGlobe Newswire • 5 months ago
As per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the forecast period 2023-2033. Visiongain has published a new report entitledRare Diseases2023-2033. It includes profiles of Rare Diseases and ...
Share to Feed
Visiongain has published a new report entitledRare Diseases2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological Conditions, Hematologic Disorders, Infectious Diseases, Musculoskeletal Disorders, Cardiovascular Disorders, ...
Visiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological Conditions, Hematologic Disorders, Infectious Diseases, Musculoskeletal Disorders, Cardiovascular Disorders...
Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company. The acquisition creates an opportunity to accelerate Alexions growth in genomic medicines through unique technology, an...
Dr James Fox explores whether AstraZeneca shares are right for his portfolio after two years of strong share-price growth.
The post If Id invested 500 in AstraZeneca shares 2 years ago, heres how much Id have now! appeared first on The Motley Fool UK.
AstraZeneca (LSE:AZN) ...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, JVA, AKUS, LOGC SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, JVA, AKUS, LOGC PR Newswire NEW YORK, Oct. 31, 2022 NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating...
LogicBio Therapeutics (NASDAQ:LOGC Get Rating) and Aziyo Biologics (NASDAQ:AZYO Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst ...
NEW YORK, Oct. 23, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Southern Missouri Bancorp, Inc. (NASDAQ: SMBC)s...
SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, Oct. 20, 2022 NEW YORK, Oct. 20, 2022 /PRNewswire/ -- If...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAWW, LOGC, RFP, PBFX, RNWK SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAWW, LOGC, RFP, PBFX, RNWK PR Newswire NEW YORK, Oct. 18, 2022 NEW YORK, Oct. 18, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is...
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
Latest LOGC News
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain
Globe Newswire • 5 months ago
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports Ltd
Globe Newswire • 6 months ago
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports Ltd
Globe Newswire • 7 months ago